Regions :: North America :: U.S.
U.K. Unveils Anti-counterfeit Drugs Program
3:46 AM MST | December 3, 2007 | Alex Scott
The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA; London) has unveiled a new three-year program to combat the sale of counterfeit drugs. The program was detailed at a recent conference on drug counterfeiting held by MHRA in London. U.K. has become a major distribution point for counterfeit drugs partly because a U.K. stamp on packaging adds an air of authenticity to products, MHRA says. MHRA says there have been nine known cases of counterfeit prescription-only medicines reaching patients through the legal supply chain in the U.K...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee